Not applicableActive Not RecruitingNCT05007483What this trial is testingEfficacy of Diet on Quality of Life in Multiple SclerosisWho this might be right forMultiple Sclerosis, Relapsing-Remitting Terry L. Wahls 162
Testing effectiveness (Phase 2)Looking for participantsNCT07502768What this trial is testingTislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell LymphomaWho this might be right forExtranodal NK/T-cell LymphomaNK/T-cell LymphomaRelapsed or Refractory NK/T-Cell Lymphoma Rong Tao 107
Not applicableStudy completedNCT07423559What this trial is testingRelapse Among Diabetic Ketoacidosis Patients Maintained Basal Bolus Insulin Administration in Combination With Continuous Intravenous Insulin Infusion VS Non Maintaining Basal Insulin PatientsWho this might be right forDiabetic KetoacidosisInsulinIntensive Care Unit Stay Tanta University 100
Testing effectiveness (Phase 2)Study completedNCT01807546What this trial is testingOral Rigosertib for Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell CarcinomaAnal Squamous Cell CarcinomaLung Squamous Cell Carcinoma+4 more Traws Pharma, Inc. 64
Early research (Phase 1)Study completedNCT00741403What this trial is testingA Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced MalignanciesWho this might be right forAdvanced CancerMetastatic CancerLymphoma+2 more Cornerstone Pharmaceuticals 39
Not applicableStudy completedNCT00222703What this trial is testingEnhancing Tobacco Abstinence Following HospitalizationWho this might be right forHospitalized SmokersChronic DiseasesTobacco Use Disorder University of Pittsburgh 80
Large-scale testing (Phase 3)Active Not RecruitingNCT04181827What this trial is testingA Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Janssen Research & Development, LLC 419
Testing effectiveness (Phase 2)Study completedNCT01001442What this trial is testingSafety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Biotest Pharmaceuticals Corporation 35
Testing effectiveness (Phase 2)Study completedNCT01202877What this trial is testingPKC412 and 5-AzacytidineWho this might be right forLeukemia M.D. Anderson Cancer Center 54
Not applicableStudy completedNCT03013257What this trial is testingHIFU vs RAI in the Relapsed Graves' DiseaseWho this might be right forGraves Disease The University of Hong Kong 240
Testing effectiveness (Phase 2)Study completedNCT00565981What this trial is testingA Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of ResponseWho this might be right forB-cell Chronic Lymphocytic Leukemia Arbeitsgemeinschaft medikamentoese Tumortherapie 10
Not applicableLooking for participantsNCT07237230What this trial is testingClinical Study to Evaluate the Safety and Efficacy of γδ T Cells for the Prevention of Relapse After Allogeneic Transplantation in Patients With High-risk Acute Myeloid LeukemiaWho this might be right forHigh-Risk Acute Myeloid Leukemia Donghua Zhang 40
Testing effectiveness (Phase 2)Looking for participantsNCT06503107What this trial is testingNanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMMWho this might be right forMultiple Myeloma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Large-scale testing (Phase 3)Study completedNCT00437307What this trial is testingHycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer RelapseWho this might be right forOvarian Cancer North Eastern German Society of Gynaecological Oncology 550
Early research (Phase 1)Study completedNCT02316964What this trial is testingDecitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more Sumithira Vasu 8
Testing effectiveness (Phase 2)UnknownNCT05918198What this trial is testingClinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Peking University People's Hospital 52
Testing effectiveness (Phase 2)Study completedNCT01006265What this trial is testingClinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple SclerosisWho this might be right forMultiple Sclerosis Actelion 464
Early research (Phase 1)Looking for participantsNCT06375044What this trial is testingStudy of SIM0500 Alone in Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forRelapsed or Refractory Multiple Myeloma Jiangsu Simcere Pharmaceutical Co., Ltd. 130
Early research (Phase 1)Looking for participantsNCT06792734What this trial is testingPhase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell LymphomasWho this might be right forLymphoma, B-Cell Bantam Pharmaceuticals 24
Large-scale testing (Phase 3)Study completedNCT00197951What this trial is testingClinical Trial With Ziprasidone for the Treatment of Psychiatric Pathology Associated to AlcoholismWho this might be right forDepressionAngerAnxiety+1 more Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 60